GH1 and neoplasm: Tumor relapse was observed in 16 patients (n = 16/94, 17%), 5 of them (n = 5/16, 31.25%) had FPAs (4 GH-secreting, 1 ACTH-secreting) and 11 NFPAs (n = 11/16, 68.7%).